HeartSciences announces completion of patient enrollment for FDA pivotal study of MyoVista wavECG
The study has enrolled more than 600 patients at five geographically dispersed centers located across the United States
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
The study has enrolled more than 600 patients at five geographically dispersed centers located across the United States
Developed in partnership with the South Korean Intelligent Design Team and Research and Developer HIRONIC, this platform offers…
SMI with technology licensed from Columbia University is developing a cloud-based targeting software based on parcel-guided rTMS (pg-rTMS).
Cambridge University Hospitals NHS Foundation Trust launched its virtual ward program in 2022, as part of a National…
Establishes an Industry Leading Repair Option for its Fast-Growing Diagnostic Imaging Division and a Long Term Partnership with…
DavLong was founded over 40 years ago to provide technology solutions for a wide range of businesses and…
Enhances TTG's continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology…
The affected tests can be identified by the lot number on the outer packaging and should be appropriately…
S.I.N. manufactures an extensive line of products to perform dental implant procedures and is focused on advancing the…
New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis